zelboraf
(Vemurafenib)Genentech, Inc.
Usage: ZELBORAF® is indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation and for Erdheim-Chester Disease (ECD) with the same mutation. It is not suitable for patients with wild-type BRAF melanoma.